An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy

NCT00004978 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4150

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Recombinant interleukin-2 (rIL-2)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]